The next few months will be tricky…
The latest core inflation number increased to 3.0%.
And with a long cycle of rate cuts in motion, you and I both know what comes next… inflation heating back up.
Prices for basic stuff are already climbing… and it may only get worse.
Look, I’m not here to dump bad news on you.
But after spending years in the trenches of the market…
Including working at a billion-dollar financial research firm,
Where my job was to create trading algorithms and strategies that we would license to clients.
And currently, sharing Wall Street’s secrets with over 190,000 traders.
I’ll tell you this…
It’s dangerous to rely only on a salary…
Or on the slow returns of one investment account.
And that’s why I went on camera to uncover an unusual escape hatch for traders like you.
A means for regular folks to target “dividends”… not in months or years,
But every single week.
And it’s from one of the biggest blue-chip stocks in the market… all by leveraging a pricing anomaly on this same stock.
An anomaly set in motion by firms like BlackRock and Vanguard.
The best part is… You don’t need to own a single share of this stock.
It only takes one trade at the start of the week.
And by Friday, if things line up, you could be looking at a payout that can help soften the blow of rising costs.
Like the week of July 21st…
All you had to do was hit a few clicks on your brokerage account to open a trade…
And by Friday, you would have cashed in a $600 “weekly dividend.”
How about on August 18th?
Same routine. Take less than 5 minutes to set up the trade on Monday…
And by the end of the week, walk away with a $1,000 payout.
Now there were smaller wins and those that didn’t work. There are bound to be winners and losers in trading.
But in a world where groceries, gas, and basic needs keep climbing… a shot at extra income every week can help offset costs.
That’s why I put together the full briefing…
To show you what these “weekly dividends” are…
The pricing anomaly on the blue chip stock…
And how you can start targeting “weekly dividends” no matter what the next inflation number reads.
If you’re Interested…
Then get the full “weekly dividends” scoop right here
By clicking the link above you agree to periodic updates from WealthPin and its partners (privacy policy)
The 3 Penny Stocks You Swore You'd Never Buy (But You'll Check Anyway)
Authored by Chris Markoch. Publication Date: 1/18/2026.
Key Points
- Vaxart is a clinical-stage biotech developing oral vaccines that could transform global immunization if its platform proves effective.
- Microvision develops cost-effective lidar technology for autonomous vehicles, with upside tied to industry adoption and potential partnerships.
- Datavault AI focuses on monetizing digital data through AI and blockchain tools, offering speculative exposure to the emerging data-as-an-asset theme.
Penny stocks attract speculative investors seeking high-risk, high-reward opportunities — often companies with disruptive technologies, exposure to an emerging trend, or a compelling turnaround story. Many of these companies will never survive or scale, but if just one delivers, investors can realize impressive returns.
For investors who believe there's strength in numbers, MarketBeat publishes a tool that lists the 100 Most Popular Penny Stocks, ranked by the number of MarketBeat subscribers following each company. While subscriber interest is not a guarantee of success, it can provide extra conviction for some investors.
Gold Breakout ALERT (Ad)
Gold to SOAR as early as January 28
Many are wondering why so many countries are frantically buying gold right now. The truth is that this is just the beginning of a much larger story... One that could send gold soaring to even bigger highs this month. But the best way to cash in on gold's upside potential might surprise you. One firm says this stock (less than $50) could be the best way to get started.
Some define a penny stock as any share trading at $5 or less. This screener, however, follows the traditional definition — stocks priced below $1. These issues are highly volatile; conduct your own research and understand your risk tolerance before initiating a position.
Vaxart: A Potential Game-Changer for Global Immunization Efforts
Vaxart Inc. (NASDAQ: VXRT) is a clinical-stage biotechnology company developing oral, tablet-based vaccines for infectious diseases such as influenza, norovirus, and COVID-19. Unlike injectable vaccines, Vaxart's platform aims to simplify distribution and improve access worldwide.
The bull case centers on that innovative approach. If Vaxart secures FDA approval and scales successfully, its oral vaccines could reduce logistical barriers to mass immunization and create significant licensing opportunities. Positive trial results or a commercial collaboration could materially change sentiment and valuation from the stock's current low base.
Clinical risk is the primary challenge. Vaxart has yet to bring a product to market, and vaccine development is costly and unpredictable. Competition from established players with larger R&D budgets also constrains visibility. For now, Vaxart is a long-term speculative bet on platform validation rather than near-term profitability.
The MarketBeat analyst ratings for Vaxart show only a single analyst covering the stock, which may raise concerns for some investors. Additionally, VXRT has about 18% institutional ownership and roughly 2% short interest, which could moderate some volatility.
Microvision: Developing Cost-Effective LiDAR Units for Autonomous Driving
Microvision Inc. (NASDAQ: MVIS) develops LiDAR (light detection and ranging) sensors for autonomous vehicles, smart infrastructure, and industrial sensing. Its hardware and software enable precise 3D mapping needed for self-driving systems and advanced driver-assistance systems (ADAS). Microvision focuses on creating compact, cost-effective LiDAR units that could appeal to automakers seeking scalable sensor solutions.
The bull case rests on two factors: continued progress toward vehicle automation and potential partnerships with major automakers. If Microvision can demonstrate performance or cost advantages, it could secure supply agreements or licensing deals that improve revenue visibility. The technology may also find applications in robotics and smart-city infrastructure, adding optionality to the growth story.
Still, Microvision faces stiff competition from LiDAR players like Luminar (NASDAQ: LAZR), Innoviz (NASDAQ: INVZ), and Ouster (NYSE: OUST). The path to profitability remains uncertain, and delays in broader LiDAR adoption continue to frustrate investors.
MVIS is covered by three analysts and carries a consensus price target of $2.50 — about a 169% upside from its Jan. 15 closing price. However, the stock has relatively low institutional ownership (around 30%) and high short interest (around 21%), so investors should expect elevated volatility.
Datavault AI: Trying to Democratize Data Ownership
Datavault AI Inc. (NASDAQ: DVLT) operates at the intersection of artificial intelligence, data monetization, and digital-asset management. The company's patented Datavault platform helps organizations convert raw data into tradable, revenue-generating assets by combining AI, blockchain, and analytics tools. Datavault AI's mission is to democratize data ownership and unlock monetization opportunities that traditional systems overlook.
The bullish thesis centers on a niche focus with scalability potential. As data becomes increasingly valuable, businesses — and potentially individuals — are seeking ways to safely monetize digital information. Datavault's technology could benefit from wider AI adoption and growing interest in data sovereignty. Early traction or strategic partnerships could catalyze investor confidence.
That said, Datavault AI operates in a largely experimental space. Its business model is still evolving, and a clear path to meaningful revenue is unproven. Institutions own less than 1% of the stock, and short interest exceeds 16% as of this writing. Investors considering DVLT should view it as a long-term, speculative position based on belief in data-as-an-asset innovation rather than near-term earnings potential.
This email message is a sponsored email sent on behalf of Wealthpin Pro, a third-party advertiser of DividendStocks.com and MarketBeat.
We develop tools and strategies to the best of our ability, but no one can guarantee the future. Past performance is not indicative of future results. From April 24, 2023, to September 16, 2025, the win rate on live published alerts was 86%, and the average return was 35% over a 3-day hold time.
If you need help with your newsletter, please don't hesitate to contact our U.S. based support team at contact@marketbeat.com.
If you no longer wish to receive email from DividendStocks.com, you can unsubscribe.
© 2006-2026 MarketBeat Media, LLC. All rights reserved.
345 North Reid Place, Suite 620, Sioux Falls, South Dakota 57103-7078. United States of America..